General Resources on COVID-19

FDA Daily Roundup – Updates, announcements, and guidance from the U.S. Food and Drug Administration (FDA)

FDA FAQs – FDA answers frequently asked questions about food, medical treatment, devices, and veterinary products amid the COVID-19 pandemic

NIH Updates – News and resources from the National Institutes of Health

CDC Updates – News and weekly surveillance report from the Centers for Disease Control and Prevention (CDC)

HHS Updates – COVID-19 information from the U.S. Department of Health and Human Services

COVID-19 Pandemic Resources – Public and technical updates, including travel advice, from the World Health Organization (WHO)

Global Research on COVID-19 – Links to clinical trials around the world  

Diagnostic Tests for COVID-19  Information on tests available for detecting SARS-CoV-2 and a list of organizations offering testing and/or test kits

Glossary of Terms – A list of common terms and definitions related to drug development and expanded access

Resources for Patients and Caregivers
Image
COVID patient


FDA Resources for Patients – Resources to help patients and caregivers cope with the COVID-19 pandemic

Hand Sanitizers and COVID-19  Answers from FDA on common questions about hand sanitizer and antibacterial soap 

Hand Sanitizer and Safety  FDA information regarding use of hand sanitizer and hygiene for consumers 

Cloth Face Masks – CDC information regarding use of clothe face masks to slow the spread of COVID-19

How to Protect Yourself – Tips on how to protect yourself and what to do if you're sick   

Know the Symptoms   List of symptoms and a self-checker 

Patients & Caregivers Guide to Expanded Access – Detailed guide to help patients and caregivers understand the process of accessing investigational drugs when a clinical trial is not an option

Resources for Healthcare Providers
Image
Healthcare provider


Blood Purification Device Authorized  FDA authorizes blood purification system to treat patients 18 and older with COVID-19

Chloroquine and Hydroxychloroquine  FDA revokes Emergency Use Authorization for Chloroquine and Hydroxychloroquine

Coronavirus Treatment Acceleration Program (CTAP)  Special emergency program created by FDA to expedite the availability of potentially safe and effective life-saving treatments

Emergency Use Authorizations – Lists current and terminated EUAs that make available diagnostic and therapeutic medical devices to diagnose and respond to public health emergencies

Expanded Access Navigator Guide for Healthcare Providers – Detailed guide to help physicians and healthcare providers request and manage access to  investigational treatments outside of a clinical trial

Guidance for IRBs and Clinical Investigators  Institutional Review Board (IRB) Review of individual patient expanded access requests for investigational drugs and biological products during the COVID-19 public health emergency

Guidance for Industry, Investigators, and Institutional Review Boards – FDA guidance on conduct of clinical trials of medical products during COVID-19 public health emergency

Hospital Beds, Stretchers, and Mattresses FDA FAQs to address questions related to design, evaluation, labeling, and marketing 

Laboratory Safety Guidance on workflow safety concerns of laboratory personnel during the COVID-19 pandemic

Medical Devices and the COVID-19 Pandemic Information from FDA on diagnostic tests, ventilators, and personal protective equipment (PPE), including masks, face shields, respirators, gowns, and gloves

Medical Gloves for COVID-19 Information from FDA on manufacturing, purchasing, importing, and donating gloves during the public health emergency

Remdesivir and chloroquine phosphate or hydroxychloroquine – Press release from FDA issuing warning of newly discovered potential drug interaction that may reduce effectiveness of a COVID-19 treatment authorized for Emergency Use

Testing Healthcare Personnel for SARS-CoV-2  CDC summary of considerations and recommendations regarding testing healthcare personnel (HCP) for SARS-CoV-2.

Therapuetic Emergency Use Authorization  Details the FDA-issued EUA allowing distribution of hydroxychloroquine sulfate and chloroquine phosphate from the Strategic National Stockpile for certain hospitalized patients with COVID-19 

Treatment Guidelines  NIH key updates to COVID-19 treatment guidelines

Treatment Summary Recommendations  NIH recommendations for care of critically ill patients with COVID-19

 

Personal Protective Equipment:

Revised EUA for Respirators –  FDA reissues Emergency Use Authorizations revising which types of respirators can be decontaminated for reuse

EUA to Detcontaminate Respirators – FDA's Emergency Use Authorization to decontaminate millions of n95 respirators

Mask and Gown Shortage FAQs Answers to frequently asked questions on shortages of surgical masks and gowns

Masks and N95 Respirators – Information about the use of N95 vs surgical or face masks

Medical Devices and the COVID-19 (Coronavirus) Pandemic  Information from FDA on diagnostic tests, ventilators, and personal protective equipment (PPE)—including masks, face shields, respirators, gowns, and gloves

Medical Glove Conservation Strategies  Letter from FDA to healthcare providers on potential shortages of surgeons' gloves and patient examination gloves

PPE Conservation  Strategies to conserve PPE and other resources

Surgical Mask and Gown Conservation Strategies  Letter from FDA to healthcare providers recommending conservation strategies for a range of need and supply levels

Facepiece respirators Letter from FDA to healthcare providers advising that certain filtering facepiece respirators from China may not provide consistent and adequate respiratory protection to health care personnel exposed to COVID-19